Sign up to save your podcasts
Or
Share E16: Tocilizumab in Giant-Cell Arteritis - GIACTA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E16: Tocilizumab in Giant-Cell Arteritis - GIACTA
Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone. It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.
View all episodes
By Michael Putman
4.9
111111 ratings
Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone. It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
315 Listeners
JAMA Clinical Reviews
498 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
Core IM | Internal Medicine Podcast
1,107 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
197 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Freely Filtered, a NephJC Podcast
168 Listeners
ACR on Air
70 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
174 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
19 Listeners